Accreditation:
The American Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACCME: The American Academy of Family Physicians designates this education activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP: This activity has been reviewed and is acceptable for up to 12.5 Prescribed credits by the American Academy of Family Physicians. Of these credits, 6.0 conform to the AAFP criteria for evidence-based CME clinical content. CME credit has been increased to reflect 2 for 1 credit for only the EB CME portion. When reporting AAFP credit, claim total Prescribed credit for this activity. It is not necessary to label credit as evidence-based for reporting purposes.

AOA: CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.

AAPA: AAPA accepts Prescribed credit from the AAFP.

AANP: This program has been approved for up to 6.5 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 0810478

Learning Objectives:

Hyperlipidemia

• Describe how primary care physicians are performing in management of hyperlipidemia;
• Rapidly assess risk stratification for coronary heart disease and its implications for lipid management;
• Apply the NCEP guidelines in practice while understanding their limitations;
• Help patients develop a “therapeutic lifestyle change”;
• Provide evidence-based interventions to optimize lipid levels using diet and drugs;
• Implement systems to enhance effectiveness of managing patients with hyperlipidemia in practice; and
• Gain appreciation of the support AAFP and its publications provide in the area of hyperlipidemia.

Immunizations

• Rank various barriers among adults and adolescents in need of immunization;
• Apply the 2008-09 CDC Adult and Adolescent Immunization Schedules to appropriate patient populations;
• Compare the efficacy of current and former vaccines for H. zoster, B. pertussis, and Human Papilloma Virus;
• Operate the “Catch-Up” schedule methodology for all adolescent patients that did not receive the necessary immunizations at the acceptable age.

Pain Management

• Recognize responsibilities prior to prescribing medications to manage pain
• Apply the proper titration schedule for each individual patient based on symptom management and side effects
• Identify follow-up plans for patients that have been prescribed medications shown to have an increased risk for misuse, abuse, and diversion
• Determine which medications are most effective for managing specific etiologies of pain

Musculoskeletal Concerns in the Pediatric Patient

• Classify growth plate fractures via the Salter-Harris Classification System
• Formulate treatment plans for pediatric musculoskeletal issues that are injury-specific
• Formulate musculoskeletal injury prevention plans for children that are injury-specific
• Integrate the parent(s) and child perspective into the injury prevention plan in order to increase the likelihood of compliance

Fibromyalgia

• Recognize the populations with the highest incidence and prevalence of fibromyalgia
• Identify the 18 specified sites identified by the American College of Rheumatology as a criteria for the classification for fibromyalgia
• Distinguish the symptoms of fibromyalgia from myofascial pain syndrome, chronic fatigue syndrome, and hypothyroidism
• Formulate treatment plans using both pharmacologic and non-pharmacologic therapies
• Measure therapeutic efficacy using the Fibromyalgia Impact Questionnaire (FIQ)

The Appropriate Use of Opioids

• Define provider responsibilities prior to prescribing opioids to manage pain and identify federal and state regulations
• Apply the proper opioid titration schedule for each individual patient based on symptom management and side effects
• Determine which medications are most effective for managing specific etiologies of pain including end of life care issues
• Identify follow-up plans for patients that have been prescribed medications shown to have an increased risk for misuse, abuse, and diversion

Target Audience:
The CME learning objectives and topics have been selected to provide the most pertinent information to family physicians, general practitioners, general internists, emergency medicine physicians, obstetricians/gynecologists, nurse practitioners and physician assistants.

Faculty:
Program Chairs:
Gary Levine, MD

Moderator:
John B. Crider, MD - Private Practice and Owner, Family Medical Clinic, LLC, Arab, AL; Medical Staff, Marshall Medical Center North, Guntersville, AL; Clinical Assistant Professor, Department of Family Practice, University of South Alabama College of Medicine, Mobile, AL; Clinical Assistant Professor, Department of Family Practice, University of Alabama School of Medicine, Mobile, AL

Presenting Faculty:
B. Wayne Blount, MD, MPH - Professor and Executive Vice Chair, Department of Family and Preventive Medicine; Program Director, Preventive Medicine Residency, Emory University School of Medicine, Atlanta, GA; Chief of Service, Family Medicine Emory John's Creek Medical Center, Atlanta, GA

Dennis Cardone, DO - Clinical Associate Professor, Department of Orthopedic Surgery, NYU Hospital for Joint Diseases, New York City, NY

John B. Crider, MD - Private Practice and Owner, Family Medical Clinic, LLC, Arab, AL; Medical Staff, Marshall Medical Center North, Guntersville, AL; Clinical Assistant Professor, Department of Family Practice, University of South Alabama College of Medicine, Mobile, AL; Clinical Assistant Professor, Department of Family Practice, University of Alabama School of Medicine, Mobile, AL

William J. Geiger, MD - Associate Professor of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, WI; Director, Columbia St. Mary's Family Medicine Residency, Milwaukee, WI

Patrick B. Wood, MD - Chief Medical Officer, Angler Biomedical Technologies, LLC, Rockville, MD

Schedule:

Support:

AAFP Live! is supported by grants from Alpharma, Merck & Co., Inc., Merck/Schering-Plough Pharmaceuticals Purdue Pharma L.P. and Pfizer.

Merck & Co., Inc. is a core supporter of the 2008 Annual Clinical Focus 'Infectious Disease: Prevention, Diagnosis & Management'

Copyright © 2008 American Academy of Family Physicians. All Rights Reserved.